Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
ENTO | Entero Therapeutics, Inc. | Chairman and CEO, Director | $38.3K | -$12.2K | -24.1% | Jul 2, 2024 |
ONCO | Onconetix, Inc. | Director | $26.1K | Sep 26, 2024 | ||
RENB | RENOVARO INC. | Director | Jun 25, 2024 | |||
ZVSA | ZyVersa Therapeutics, Inc. | Director | May 24, 2023 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|